Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · IEX Real-Time Price · USD
41.59
-0.25 (-0.60%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Ionis Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1995
Cash & Equivalents
399.27276.47869.19397.66683.29278.82129.6384.69128.8143
Upgrade
Short-Term Investments
1,9321,7101,2461,4951,8161,805893.09580.54675.18667.72
Upgrade
Cash & Cash Equivalents
2,3311,9872,1151,8922,5002,0841,023665.22803.98810.71
Upgrade
Cash Growth
17.33%-6.06%11.76%-24.29%19.94%103.78%53.74%-17.26%-0.83%14.37%
Upgrade
Receivables
97.7825.5461.976.263.0312.7662.96108.0411.363.9
Upgrade
Inventory
28.4322.0324.8121.9718.188.589.987.496.96.29
Upgrade
Other Current Assets
184.45168.25143.37140.16139.84102.4773.0817.1814.7715.69
Upgrade
Total Current Assets
2,6422,2032,3452,1312,7212,2081,169797.93837836.6
Upgrade
Property, Plant & Equipment
242.94255.84196.04181.08153.65132.16121.9192.8590.2388.96
Upgrade
Goodwill and Intangibles
00027.9425.6724.032220.3719.3217.19
Upgrade
Other Long-Term Assets
105.2875.3470.650.03333.19303.7110.131.331.3513.07
Upgrade
Total Long-Term Assets
348.22331.18266.64259.05512.52459.9154.04114.54110.9119.21
Upgrade
Total Assets
2,9902,5342,6122,3903,2332,6681,323912.47947.9955.81
Upgrade
Accounts Payable
26.0317.9211.917.216.0728.6624.8921.1228.3617.98
Upgrade
Deferred Revenue
392.31378.35449.59532.42608.33727.62233.36142.48201.63179.51
Upgrade
Current Debt
44.3300316.112.0313.751.621.199.032.88
Upgrade
Other Current Liabilities
-14.58-84.71-220.95-266.83-353.42-489.73-16.26-31-90.14-85.04
Upgrade
Total Current Liabilities
448.09311.56240.55598.9273.01280.29243.61133.78148.88115.33
Upgrade
Long-Term Debt
1,4001,3621,248623.53785.5632.97605.86587.92463.93454.9
Upgrade
Other Long-Term Liabilities
754.92287.77351.88424.05490.06567.36108.0391.2134.31127.8
Upgrade
Total Long-Term Liabilities
2,1551,6491,5991,0481,2761,200713.88679.12598.23582.7
Upgrade
Total Liabilities
2,6031,9611,8401,6461,5491,481957.49812.9747.11698.03
Upgrade
Total Debt
1,4451,3621,248939.64787.53646.72607.48589.11472.96457.78
Upgrade
Debt Growth
6.10%9.15%32.77%19.32%21.77%6.46%3.12%24.56%3.31%96.83%
Upgrade
Retained Earnings
-1,795.91-1,429.63-1,159.9-1,131.31-707.53-967.29-1,241.03-1,181.43-1,094.87-1,006.59
Upgrade
Comprehensive Income
-32.65-57.48-32.67-21.07-25.29-32.02-31.76-30.36-13.5739.75
Upgrade
Shareholders' Equity
386.69572.89771.74743.281,4711,048281.0199.57200.79257.78
Upgrade
Net Cash / Debt
886.49625.21867.45952.741,7121,437415.2476.12331.02352.93
Upgrade
Net Cash / Debt Growth
41.79%-27.93%-8.95%-44.35%19.11%246.15%445.52%-77.00%-6.21%-25.90%
Upgrade
Net Cash Per Share
6.194.416.156.8211.1810.723.290.632.763.00
Upgrade
Working Capital
2,1941,8912,1041,5322,4481,928925.12664.15688.13721.27
Upgrade
Book Value Per Share
2.704.045.475.3210.517.922.270.821.682.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).